Services
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Acquisitions

Sales / Divestitures
Sectors
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Aerospace & Defence

Automotive

Business Services

Consumer Products
Energy & Mining

Food & Beverage

Healthcare & Pharmaceuticals

Industrials
Leisure

Maritime & Offshore

Packaging

Technology
Transactions
Advisors
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
Please, choose your cross-border team

REACH M&A Advisory Firms
About us
Specializing in mid-market transactions, we advise private equity funds, corporate clients, and family-owned companies aiming to sell, divest, acquire, or merge businesses across international borders.
About

Insights

News

Contact

Divestiture of Celsis IVT, a provider of in vitro products for the study of drug metabolism and toxicity

Target Company Name:
Country:
Advisory:
Sector:
Partner:

Celsis In Vitro Technologies
USA
Advisor to the seller
Healthcare & Pharmaceuticals
Brown Gibbons Lang & Company

Divestiture of Celsis IVT, a provider of in vitro products for the study of drug metabolism and toxicity

Celsis In Vitro Technologies

Bioreclamation, LLC

Divestiture of Celsis IVT, a provider of in vitro products for the study of drug metabolism and toxicity

Advisor to the seller :
Brown Gibbons Lang & Company

Experts who worked on this transaction

John Riddle

John Riddle

Managing Director & Principal at Brown Gibbons Lang & Company

Relevant transactions

Project Amygdala

Private Equity

Sale of mental health services provider for high-acuity individuals in the UK

Advisor to the seller :
Cooper Parry Corporate Finance

Genbio

Private Investors

Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors

Advisor to the seller :
RIóN

icotec

MVM Partners

icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM

Alpha Source Group

Probo Medical

Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.

Advisor to the seller :
Brown Gibbons Lang & Company